PDF-ANTIMICROBIAL

Faces of Resistance. Audit.  .  . A brief introduction for . <Your Facility> . clinicians. What is the 5x5 Antimicrobial Audit?. A continuous . audit activity that collects information about empirical antimicrobial . Audit.  . Interventions in Practice. <Facilitator/Trainer Name>. <Date>. Disclaimer. The information on the following slides are designed to allow healthcare professionals to practice interventions for the 5x5 Antimicrobial Audit. Presenter. date. Supporting healthcare professionals . in the fight against resistance. Expand the standardized antimicrobial web based PPS at a global scale to collect consistent, valid and comparable antimicrobial prescribing data.. IP Boot Camp Day 3:. Today’s plan. What is AMS?. How do I do it?. How do we know it’s working?. Quick plug- Help us with a survey!. AK is participating in an initiative to get stewardship in every LTC!. Shira Doron, MD. Assistant Professor of Medicine. Associate Hospital . Epidemiologist. Tufts Medical Center. What is Antimicrobial Stewardship?. Antimicrobial stewardship involves the . optimal. selection, dose and duration. January 21, 2016. Presented by Jill Hanson, WHA. Objectives for Today. Importance of an Antimicrobial Stewardship Program (ASP). What is occurring on the national level . What is occurring on the state level. Regulations. An Environment of Change. Brian Lubbers, DVM, PhD, . DACVCP. Director of Clinical Microbiology. Changing Regulations. Cephalosporin . Extralabel. Use Restriction. FDA Guidance 209. FDA Guidance 213. . Dr Andrea Ammon, ECDC Director, . 27 June 2017, European Parliament. 0. 200. 400. 600. 800. 1000. 1900. 1920. 1940. 1960. 1980. 2000. 1918. Influenza pandemic. 1924. Plague: last human-to-human transmission. The Joint Commission. AAHP Fall Seminar 2017. Marsha Crader, . PharmD. Mandy Langston, . PharmD. Megan Patch, MS, . PharmD. , BCPS. Elizabeth Smith, . PharmD. /Sarah Cochran, . PharmD. Pharmacist Learning . Therapy. The development of antimicrobial drugs represents one of the most important advances in therapeutics, both in the control or cure of serious infections and in the prevention and treatment of infectious complications of other therapeutic modalities such as cancer chemotherapy, immunosuppression, and surgery.. Keith Hamilton, MD. Director of Antimicrobial Stewardship. Hospital of the University of Pennsylvania. Disclosures. Nothing to disclose. Outline. Background. Case for regional approaches to stewardship. Resistance : T ackling a crisis for the health and wealth of nations The Review on Antimicrobial Resistance Chaired by Jim O’Neill December 2014 Contents What is antimicrobial resistance? RESISTANCE Interagency Task Force on Antimicrobial Resistance Co - Chairs: Centers for Disease Control and Prevention Food and Drug Administration National Institutes of Health Participating Agencie s Javier . A. . Adachi, MD. Department . of Infectious Diseases, Infection Control & Employee . Health. The University of Texas – M.D. Anderson Cancer Center. . UT System Inaugural CS&E Conference, Austin.